| Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption (vol 22, 71, 2020) J Eriksson, E Sjogren, H Lennernas, H Thorn AAPS JOURNAL 23 (1), 2021 | 1 | 2021 |
| Correction to: Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption J Eriksson, E Sjögren, H Lennernäs, H Thörn The AAPS Journal 23 (1), 2021 | | 2021 |
| Pulmonary drug absorption and systemic exposure in human: Predictions using physiologically based biopharmaceutics modeling J Eriksson, H Thörn, H Lennernäs, E Sjögren European Journal of Pharmaceutics and Biopharmaceutics 156, 191-202, 2020 | 17 | 2020 |
| IMI–Oral biopharmaceutics tools project–Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling … A Ahmad, X Pepin, L Aarons, Y Wang, AS Darwich, JM Wood, ... European Journal of Pharmaceutics and Biopharmaceutics 156, 50-63, 2020 | 28 | 2020 |
| Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption J Eriksson, E Sjögren, H Lennernäs, H Thörn The AAPS Journal 22, 1-12, 2020 | 18 | 2020 |
| Experimental evidence of regional lung deposition differences effecting the systemic exposure in dog S Oag, H Thorn, U Tehler JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 33 (2), A27-A27, 2020 | 1 | 2020 |
| Pulmonary dissolution of poorly soluble compounds studied in an ex vivo rat lung model J Eriksson, H Thörn, E Sjögren, L Holmstén, K Rubin, H Lennernäs Molecular Pharmaceutics 16 (7), 3053-3064, 2019 | 26 | 2019 |
| Ranking in vitro dissolution of orally inhaled drug substance powders in a time-efficient manner F Franek, L Nilsson, H Thörn, R Fransson, U Tehler J. Aerosol Med. Pulm. Drug Delivery 32, A17, 2019 | 2 | 2019 |
| Ranking in vitro dissolution of inhaled micronized drug powders including a candidate drug with two different particle sizes F Franek, R Fransson, H Thorn, P Backman, PU Andersson, U Tehler Molecular pharmaceutics 15 (11), 5319-5326, 2018 | 30 | 2018 |
| Deposition modelling of inhaled aclidinium and budesonide and comparison to gamma scintigraphy measurement H Thorn, T Loof, G Petersson, F Franek, R Fransson, U Tehler Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2018 | 2 | 2018 |
| Investigation of pulmonary drug permeability and tissue retention by computational analysis of rat ex vivo lung absorption profiles J Eriksson, E Sjogren, H Thorn, K Rubin, P Backman, H Lennernas JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 31 (2), A8-A9, 2018 | | 2018 |
| Biorelevant and flexible dose deposition of drug substance powders and nebulised liquids onto filters and cell-cultures F Franek, G Yousef, KB Sivars, H Thorn, R Fransson, U Tehler JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 31 (2), A17-A18, 2018 | 1 | 2018 |
| Lung-Sim: a physiologically based biopharmaceutical prediction tool U Tehler, R Fransson, H Thorn, F Franek, J Westergren Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2018 | 8 | 2018 |
| Pulmonary absorption–estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis J Eriksson, E Sjögren, H Thörn, K Rubin, P Bäckman, H Lennernäs European Journal of Pharmaceutics and Biopharmaceutics 124, 1-12, 2018 | 44 | 2018 |
| Reply to “Comment on ‘In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models’” E Sjögren, H Thörn, C Tannergren Molecular Pharmaceutics 14 (1), 340-343, 2017 | 6 | 2017 |
| IMI–Oral biopharmaceutics tools project–Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results A Margolskee, AS Darwich, X Pepin, L Aarons, A Galetin, ... European Journal of Pharmaceutical Sciences 96, 610-625, 2017 | 66 | 2017 |
| IMI–Oral biopharmaceutics tools project–Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across … AS Darwich, A Margolskee, X Pepin, L Aarons, A Galetin, ... European Journal of Pharmaceutical Sciences 96, 626-642, 2017 | 48 | 2017 |
| In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models E Sjögren, H Thorn, C Tannergren Molecular pharmaceutics 13 (6), 1763-1778, 2016 | 88 | 2016 |
| Binding Processes Determine the Stereoselective Intestinal and Hepatic Extraction of Verapamil in Vivo HA Thörn, E Sjögren, PA Dickinson, H Lennernäs Molecular Pharmaceutics 9 (11), 3034-3045, 2012 | 7 | 2012 |
| Extensive intestinal glucuronidation of raloxifene in vivo in pigs and impact for oral drug delivery HA Thörn, M Yasin, PA Dickinson, H Lennernäs Xenobiotica 42 (9), 917-928, 2012 | 14 | 2012 |
